Agios Pharmaceuticals Balance Sheet (2012-2026)

Reported Financials

Agios Pharmaceuticals Quarterly Balance Sheet

Periods 57 quarters

Latest Jun 2026

Agios Pharmaceuticals reported total assets of $1.11B and total liabilities of $0.08B for the quarter ended Jun 2026, down 24.7% year over year. This balance sheet covers 57 quarters of results from Jun 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Accumulated Depreciation
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.40B	0.20B	0.08B	0.09B	0.12B	0.14B	0.10B	0.08B	0.06B	0.09B	0.12B	0.08B	0.25B	0.08B	0.08B	0.08B	0.09B	0.09B	0.11B	0.10B
Receivables - NetNet Receivables			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.02B	0.02B
Receivables - OtherOther Receivables	-0.00B		0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B		0.02B	0.00B
Receivables			0.01B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.03B	0.03B
Inventory			0.00B	0.00B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.03B	0.03B	0.03B	0.03B	0.03B	0.03B	0.04B	0.03B
Prepaid Assets	0.03B	0.04B	0.04B	0.04B	0.05B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.03B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.05B	0.05B
Current Deferred Tax Assets
Current Assets	1.31B	1.06B	0.98B	0.87B	0.78B	0.83B	0.79B	0.76B	0.70B	0.83B	0.66B	0.63B	1.07B	0.97B	0.97B	1.02B	1.03B	0.94B	0.83B	0.72B
Non-Current Assets
Property, Plant & Equipment (Net)	0.03B	0.03B	0.03B	0.03B	0.03B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Long-Term Investments	0.13B	0.27B	0.26B	0.28B	0.30B	0.31B	0.27B	0.24B	0.22B	0.03B	0.12B	0.08B	0.66B	0.64B	0.53B	0.40B	0.30B	0.31B	0.31B	0.35B
Long-Term Deferred Tax
Other Non-Current Assets	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B
Non-Current Assets	0.24B	0.37B	0.36B	0.38B	0.40B	0.41B	0.36B	0.33B	0.30B	0.10B	0.19B	0.14B	0.72B	0.70B	0.59B	0.45B	0.35B	0.36B	0.35B	0.39B
Assets	1.54B	1.44B	1.34B	1.25B	1.18B	1.24B	1.15B	1.09B	1.01B	0.94B	0.85B	0.77B	1.79B	1.66B	1.56B	1.47B	1.39B	1.30B	1.18B	1.11B
Liabilities
Current Liabilities
Accounts Payables	0.01B	0.02B	0.01B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.01B	0.02B	0.02B	0.02B	0.01B	0.02B
Payables	0.01B	0.02B	0.01B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.01B	0.02B	0.02B	0.02B	0.01B	0.02B
Accumulated Expenses	0.03B	0.03B	0.02B	0.03B	0.03B	0.03B	0.02B	0.03B	0.03B	0.04B	0.03B	0.04B	0.03B	0.05B	0.02B	0.04B	0.04B	0.05B	0.03B	0.03B
Other Accumulated Expenses
Current Leases	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B
Current Taxes	0.01B												0.05B	0.00B	0.00B
Current Deferred Revenue			0.00B
Total Current Liabilities	0.06B	0.06B	0.05B	0.05B	0.05B	0.06B	0.05B	0.06B	0.06B	0.07B	0.05B	0.06B	0.12B	0.08B	0.05B	0.07B	0.07B	0.08B	0.06B	0.07B
Non-Current Liabilities
Capital Leases		0.00B	0.00B
Non-Current Deffered Revenue
Liabilities from Discontinued Operations
Operating Leases	0.10B	0.09B	0.09B	0.09B	0.09B	0.07B	0.08B	0.08B	0.08B	0.06B	0.07B	0.06B	0.06B	0.04B	0.05B	0.05B	0.04B	0.02B	0.04B	0.03B
Other Non-Current Liabilities				0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Total Non-Current Liabilities		0.15B		0.13B	0.13B	0.13B	0.11B	0.12B	0.12B	0.12B	0.10B	0.11B	0.16B	0.12B	0.09B	0.10B	0.10B	0.10B	0.08B	0.08B
Total Liabilities	0.15B	0.15B	0.13B	0.13B	0.13B	0.14B	0.11B	0.12B	0.12B	0.13B	0.11B	0.11B	0.17B	0.12B	0.09B	0.10B	0.10B	0.10B	0.08B	0.08B
Shareholder's Equity
Common Equity	1.39B	1.29B	1.21B	1.12B	1.05B	1.10B	1.04B	0.96B	0.89B	0.81B	0.74B	0.66B	1.63B	1.54B	1.47B	1.37B	1.28B	1.19B	1.11B	1.03B
Liabilities and Shareholders Equity	1.54B	1.44B	1.34B	1.25B	1.18B	1.24B	1.15B	1.09B	1.01B	0.94B	0.85B	0.77B	1.79B	1.66B	1.56B	1.47B	1.39B	1.30B	1.18B	1.11B
Treasury Shares	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	16.22B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B
Retained Earnings	-0.14B	-0.24B	-0.33B	-0.43B	-0.51B	-0.47B	-0.55B	-0.64B	-0.73B	-0.82B	-0.90B	-1.00B	-0.05B	-0.15B	-0.24B	-0.35B	-0.45B	-0.56B	-0.66B	-0.76B
Preferred Shares

Agios Pharmaceuticals AGIO Balance Sheet (2012-2026)

Agios Pharmaceuticals Quarterly Balance Sheet

Create an account

Sign In

Reset Password